MPD drug trials are opening in the UK:

• JAK2 inhibitor study will open in 8 UK centres including London, Sheffield, Oxford, Cambridge, Glasgow, Newcastle, Cardiff and Belfast (for patients with MF). Read the latest Incyte press release or visit the Incyte website for more information
  
  
• Vorinostat study will be open in 6 UK centres including London, Sheffield, Oxford, Cambridge, Manchester and Belfast (for patients with PV or ET)
  

Click on the links below to read more about what's happening in MPD research:

News of the JAK2 inhibitor drug trials

JAK2: Fast facts

JAK2: Your questions answered

More mutations discovered (December 2009 update)

Research papers

The MPD Support Charity is raising funds to provide information and support to patients with myeloproliferative disease, and to help fund research towards a cure. Please help our work.